Healthcare & Medical Devices Global On demand · 24-48h

Global Pulmonary Function Testing Equipment Market Strategic Research Report

Global Pulmonary Function Testing Equipment Market Strategic…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Pulmonary Function Testing Equipment Market
$2.54B2025
6.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single-Function Devices, Multi-Parameter Integrated Devices, Others

By Application: Hospital, Specialist Clinic, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: ndd Medizintechnik, MGC Diagnostics, Vitalograph, SCHILLER, COSMED, Philips Healthcare, GE HealthCare, Nihon Kohden, Minato Medical Science, CHEST M.I., GANSHORN Medizin Electronic, PulmOne, Morgan Scientific, KoKo PFT, Midmark, Geratherm Respiratory

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 126 pages
Market size 2025
$2.54B
Billion USD
Forecast CAGR
6.2%
2025-2032
Forecast 2032
$3.9B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Pulmonary Function Testing Equipment market size is predicted to grow from US$ 2,536 million in 2025 to US$ 3,825 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

In 2025, global Pulmonary Function Testing Equipment production reached approximately 0.648 M Units.The average price is approximately $4,000.Pulmonary Function Testing Equipment refers to a class of medical equipment systems used to objectively measure and evaluate lung ventilation, lung volume, airway resistance, gas exchange, and exercise-related respiratory functions. It is widely used in the screening, diagnosis, classification, efficacy evaluation, and long-term follow-up management of respiratory diseases.

Gross Profit Margin LevelsThe gross profit margin of pulmonary function testing equipment exhibits a typical tiered structure of "hardware platform + software functionality + repurchased consumables/services." Portable/desktop models, due to higher homogeneity and transparent channel pricing, have gross profit margins that depend more on large-scale manufacturing and channel efficiency. System-type products such as volumetric scanning chambers, DLCO/gas exchange systems, and CPET involve more complex sensing and gas analysis modules, calibration systems, compliance documentation, and installation and delivery, often possessing stronger solution attributes and premium pricing power. More importantly, the PFT workflow is naturally tied to disposable bite plates/filters, calibration consumables, software licenses, maintenance, and on-site calibration services. These "high-margin repurchase items" significantly increase the overall gross profit margin of leading manufacturers, gradually shifting industry profits from "selling equipment" to "selling platforms and full lifecycle capabilities."

Industry Drivers

The core driver of growth in the PFT (Pulsed Filtration Therapy) device market is the long-term increase in demand for chronic respiratory diseases and early screening: the increasing burden of diseases such as COPD and asthma, coupled with an aging population, has led to a continuous expansion of demand for primary care screening, outpatient follow-up, and in-hospital refined genotyping testing. Simultaneously, increased attention to respiratory health post-pandemic and the normalization of perioperative pulmonary function assessment and rehabilitation management have driven hospitals and chain institutions to expand their pulmonary function laboratories and portable testing facilities. Industry reports also generally emphasize the market-driving effect of "increasing prevalence of respiratory diseases, enhanced diagnostic awareness, and technological innovation." Furthermore, the increased adoption of advanced tests such as gas exchange and CPET in clinical practice and research, combined with enhanced equipment miniaturization, digital quality control, and remote data management capabilities, is also driving the equipment's expansion and widespread adoption from specialized laboratories to more scenarios.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pulmonary Function Testing Equipment market?

What factors are driving Pulmonary Function Testing Equipment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pulmonary Function Testing Equipment market opportunities vary by end market size?

How does Pulmonary Function Testing Equipment break out by Type, by Application?

This report presents a comprehensive overview of the global Pulmonary Function Testing Equipment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Single-Function Devices
  • Multi-Parameter Integrated Devices
  • Others

Segment by Equipment Form

  • Handheld
  • Desktop

Segment by Core Detection Principle

  • Flow-Sensor Spirometer
  • Pulse-Tracking Spirometer
  • Others

Segment by Application

  • Hospital
  • Specialist Clinic
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pulmonary Function Testing Equipment market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Specialist Clinic, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Pulmonary Function Testing Equipment Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.54B
2025
Forecast
$3.9B
2032
CAGR
6.2%
2025–2032
Regions
5
global
Key companies
ndd MedizintechnikMGC DiagnosticsVitalographSCHILLERCOSMEDPhilips HealthcareGE HealthCareNihon Kohden
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single-Function DevicesMulti-Parameter Integrated DevicesOthers
By Application
HospitalSpecialist ClinicOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Single-Function Devices
  • 3.1.3 Multi-Parameter Integrated Devices
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Specialist Clinic
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 ndd Medizintechnik
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 MGC Diagnostics
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Vitalograph
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 SCHILLER
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 COSMED
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Philips Healthcare
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 GE HealthCare
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Nihon Kohden
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Minato Medical Science
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 CHEST M.I.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 GANSHORN Medizin Electronic
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 PulmOne
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Morgan Scientific
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 KoKo PFT
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Midmark
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Geratherm Respiratory
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Pulmonary Function Testing Equipment market?
The global Pulmonary Function Testing Equipment market is estimated at US$ 2.54 billion in 2025 (base year) and is projected to reach US$ 3.83 billion by 2032.
How fast is the Pulmonary Function Testing Equipment market expected to grow?
The market is expected to grow at a CAGR of 6.2% from 2026 to 2032, expanding from US$ 2.54 billion in 2025 to US$ 3.83 billion in 2032, roughly 1.5 times its base-year value.
What does the Pulmonary Function Testing Equipment market cover?
In 2025, global Pulmonary Function Testing Equipment production reached approximately 0.648 M Units.The average price is approximately $4,000.Pulmonary Function Testing Equipment refers to a class of medical equipment systems used to objectively measure and evaluate lung ventilation, lung volume, airway resistance, gas exchange, and exercise-related respiratory functions. It is widely used in the screening, diagnosis, classification, efficacy evaluation, and long-term follow-up management of respiratory diseases.
What are the main segments of the Pulmonary Function Testing Equipment market by type?
By type, the market is segmented into Single-Function Devices, Multi-Parameter Integrated Devices and Others.
Which applications drive demand in the Pulmonary Function Testing Equipment market?
Key applications covered include Hospital, Specialist Clinic and Others.
Who are the key players in the Pulmonary Function Testing Equipment market?
Key players profiled include ndd Medizintechnik, MGC Diagnostics, Vitalograph, SCHILLER, COSMED, Philips Healthcare, GE HealthCare and Nihon Kohden, among 16 companies covered in total.
Which regions and countries are covered for Pulmonary Function Testing Equipment?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Pulmonary Function Testing Equipment market?
Simultaneously, increased attention to respiratory health post-pandemic and the normalization of perioperative pulmonary function assessment and rehabilitation management have driven hospitals and chain institutions to expand their pulmonary function laboratories and portable testing facilities.
Who should buy the Pulmonary Function Testing Equipment market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Specialist Clinic and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Pulmonary Function Testing Equipment market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.